The DOI matches its Crossref record; 486 of the 486 references it cites were found in a registry or an index.
Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–486 of 486
Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction
Cordeaux, Y., Nickolls, S. A., Flood, L. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008644200 · Cited by 69
Howard, O. M. Z., Shirakawa, A., Turpin, J. A., Maynard, A. T., Tobin, G. J., Carrington, M. N., Oppenheim, J. J., & Dean, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16228 · Cited by 69
Ghosh, R. N., DeBiasio, R., Hudson, C. C., Ramer, E. R., Cowan, C. L., & Oakley, R. H. (2005) · SLAS DISCOVERY · doi:10.1177/1087057105274896 · Cited by 69
Ryman-Rasmussen, J. P., Nichols, D. E., & Mailman, R. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012153 · Cited by 69
Statistical Thermodynamic Linkage Between Conformational And Binding Equilibria
Freire, E. (1998) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60654-3 · Cited by 68
Tan, Y., Couvineau, A., Murail, S., Ceraudo, E., Neumann, J., Lacapère, J.-J., & Laburthe, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513305200 · Cited by 68
Pellissier, L. P., Sallander, J., Campillo, M., Gaven, F., Queffeulou, E., Pillot, M., Dumuis, A., Claeysen, S., Bockaert, J., & Pardo, L. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053686 · Cited by 68
Lu, Z.-L., Gallagher, R., Sellar, R., Coetsee, M., & Millar, R. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413520200 · Cited by 67
Dimer-based model for heptaspanning membrane receptors
Franco, R., Casadó, V., Mallol, J., Ferré, S., Fuxé, K., Cortés, A., Ciruela, F., Lluís, C., & Canela, E. I. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.010 · Cited by 66
Wise, A., Sheehan, M., Rees, S., et al. (1999) · Biochemistry · doi:10.1021/bi982054f · Cited by 65
Nakamura, K., Hipkin, R. W., & Ascoli, M. (1998) · Molecular Endocrinology · doi:10.1210/me.12.4.580 · Cited by 64
Evidence for Allosteric Interactions of Antagonist Binding to the Smoothened Receptor
Rominger, C. M., Bee, W. T., Copeland, R. A., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152090 · Cited by 63
Udawela, M., Christopoulos, G., Tilakaratne, N., Christopoulos, A., Albiston, A. L., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021915 · Cited by 63
Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance
Bosier, B., & Hermans, E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.001 · Cited by 62
Brea, J. M., Castro, M., Giraldo, J., López‐Giménez, J. F., Padín, J. F., Quintián, F., Cadavid, M. I., Vilaró, M. T., Mengod, G., Berg, K. A., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054395 · Cited by 62
Holst, B., Frimurer, T. M., Mokrosiński, J., Halkjaer, T., Cullberg, K. B., Underwood, C. R., & Schwartz, T. W. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049189 · Cited by 61
Giorelli, M., Livrea, P., & Trojano, M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.05.013 · Cited by 60
Picchio, M. C., Scala, E., Pomponi, D., Caprini, E., Frontani, M., Angelucci, I., Mangoni, A., Lazzeri, C., Perez, M., Remotti, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0602 · Cited by 59
Molecular determinants of angiotensin II type 1 receptor functional selectivity
Aplin, M., Bonde, M. M., & Hansen, J. L. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.123 · Cited by 58
Gekko, K., Obu, N., Li, J., & Lee, J. C. (2004) · Biochemistry · doi:10.1021/bi036271e · Cited by 58
Gaudreau, R., Gouill, C. L., Venne, M.-H., Staňková, J., & Rola‐Pleszczynski, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202723200 · Cited by 58
Thomas, R. L., Mistry, R., Langmead, C. J., Wood, M. D., & Challiss, R. A. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141788 · Cited by 57
Lu, Z.-L., Coetsee, M., White, C. D., & Millar, R. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610413200 · Cited by 56
Arrestins as Multi-Functional Signaling Adaptors
Gurevich, V. V., Gurevich, E. V., & Cleghorn, W. M. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_2 · Cited by 56
MacKinnon, A. C., Waters, C. M., Jodrell, D. I., Haslett, C., & Sethi, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009772200 · Cited by 54
Onaran, H., Scheer, A., Cotecchia, S., & Costa, T. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57081-0_9 · Cited by 54
Ryman-Rasmussen, J. P., Griffith, A. R., Oloff, S., Vaidehi, N., Brown, J. T., Goddard, W. A., & Mailman, R. B. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.028 · Cited by 52
Tutor, A. S., Penela, P., & Mayor, F. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.022 · Cited by 52
A unique mechanism of -blocker action: Carvedilol stimulates -arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Cited by 52
Pharmacological Onomastics: What's in a name?
Kenakin, T. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707407 · Cited by 51
Self-citationBeta-Blockers in Heart Failure: Are Pharmacological Differences Clinically Important?
Metra, M., Cas, L. D., Lenarda, A. D., & Poole-Wilson, P. A. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000046367.99002.a4 · Cited by 51
Gao, F., Harikumar, K. G., Dong, M., Lam, P. C. ‐., Sexton, P. M., Christopoulos, A., Bordner, A. J., Abagyan, R. A., & Miller, L. J. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055756 · Cited by 51
Self-citationEnsemble‐based signatures of energy propagation in proteins: A new view of an old phenomenon
Liu, T., Whitten, S. T., & Hilser, V. J. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20749 · Cited by 51
Romagnoli, R., Baraldi, P. G., Carriòn, M. D., Lopez-Cara, L. C., Cruz‐López, O., Iaconinoto, M. A., Preti, D., Shryock, J. C., Moorman, A. R., Vincenzi, F., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800586p · Cited by 50
Acetylcholinesterase inhibitors for Alzheimer's disease
Flicker, L. A. (1999) · BMJ · doi:10.1136/bmj.318.7184.615 · Cited by 49
Vroon, A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00050-x · Cited by 49
Nickolls, S. A., Fleck, B. A., Hoare, S. R. J., & Maki, R. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083337 · Cited by 49
Signal Switching, Crosstalk, and Arrestin Scaffolds
Smith, N. J., & Luttrell, L. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000232641.84521.92 · Cited by 48
Pommier, B., Nascimento, S. D., Dumont, S., Bellier, B., Million, E., Garbay, C., Roques, B. P., & Noble, F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730281.x · Cited by 48
Narita, M., Suzuki, M., Narita, M., Niikura, K., Nakamura, A., Miyatake, M., Yajima, Y., & Suzuki, T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.046 · Cited by 48
Gao, Z.-G., & Jacobson, K. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.02.008 · Cited by 46
Harikumar, K. G., Happs, R. M., & Miller, L. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.008 · Cited by 45
Self-citationAgonist‐induced conformational changes in the β2 adrenergic receptor
Kobilka, B. K. (2002) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2002.21062.x · Cited by 45
Lin, C. W., Bianchi, B., Miller, T. R., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12376-8 · Cited by 45
Spijker, P., Vaidehi, N., Freddolino, L., Hilbers, P. A. J., & Goddard, W. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511329103 · Cited by 44
Lindner, A. B., Eshhar, Z., & Tawfik, D. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2309 · Cited by 44
Kenakin, T. (2007) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890701509000 · Cited by 43
Self-citationAllouche, S., Polastron, J., Hasbi, A., Homburger, V., & Jauzac, P. (1999) · Biochemical Journal · doi:10.1042/bj3420071 · Cited by 42
Blackburn, M. E., Veloro, A. M., & Fanucci, G. E. (2009) · Biochemistry · doi:10.1021/bi901201q · Cited by 42
Agonist-specific regulation of the δ-opioid receptor
Varga, E. V., Navratilova, E., Stropova, D., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.07.020 · Cited by 41
Agonist trafficking of Gi/o‐mediated α2A‐adrenoceptor responses in HEL 92.1.7 cells
Kukkonen, J. P., Jansson, C. C., & Åkerman, K. E. O. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703964 · Cited by 40
Flexibility of Helix 2 in the Human Glutathione Transferase P1-1
Stella, L., Caccuri, A. M., Rosato, N., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23267 · Cited by 40
Tran, J. A., Chang, A. L., Matsui, M., & Ehlert, F. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051276 · Cited by 40
Anborgh, P. H. (2000) · Molecular Endocrinology · doi:10.1210/me.14.12.2040 · Cited by 38
Muscarinic Receptor Agonists in Alzheimer??s Disease
Fisher, A. (1999) · CNS Drugs · doi:10.2165/00023210-199912030-00004 · Cited by 37
AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins
Lanier, S. M. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.03.012 · Cited by 37
G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors
Verkaar, F., van Rosmalen, J. W. G., Blomenröhr, M., van Koppen, C. J., Blankesteijn, W. M., Smits, J. F. M., & Zaman, G. J. R. (2008) · Biotechnology annual review · doi:10.1016/s1387-2656(08)00010-0 · Cited by 36
Johnson, M. P., Nisenbaum, E. S., Large, T. H., Emkey, R., Baez, M., & Kingston, A. E. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320881 · Cited by 36
Moniri, N. H., Covington-Strachan, D., & Booth, R. G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070086 · Cited by 35
Hanson, B. J., Wetter, J. A., Bercher, M. R., Kopp, L., Fuerstenau-Sharp, M., Vedvik, K. L., Zielinski, T. K., Doucette, C., Whitney, P., & Revankar, C. M. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109335260 · Cited by 35
Rogez, C., Martin, M. C., Dereuddre‐Bosquet, N., Martal, J., Dormont, D., & Clayette, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12914-12920.2003 · Cited by 34
Ligand-Directed Signaling: 50 Ways to Find a Lover
Michel, M. C., & Alewijnse, A. E. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.040923 · Cited by 34
Nieslanik, B. S., Dabrowski, M. J., Lyon, R. P., et al. (1999) · Biochemistry · doi:10.1021/bi9829130 · Cited by 33
Beyermann, M., Heinrich, N., Fechner, K., Furkert, J., Zhang, W., Kraetke, O., Bienert, M., & Berger, H. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707293 · Cited by 33
On the fitting of binding data when receptor dimerization is suspected
Giraldo, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.234 · Cited by 31
Meller, E., Puza, T., Diamond, J., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10372-8 · Cited by 31
Manning, D. R. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.451 · Cited by 29
Kostenis, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873734 · Cited by 27
Jones, B. W., & Hinkle, P. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045948 · Cited by 26
AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins
Lanier, S. M. (2004) · Biology of the Cell · doi:10.1111/j.1768-322x.2004.tb01428.x · Cited by 26
Goudet, C., Binet, V., Prézeau, L., & Pin, J. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.08.017 · Cited by 25
Collateral efficacy as a pharmacological problem applied to new drug discovery
Kenakin, T. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.7.635 · Cited by 25
Self-citationProposed arrangement of the seven transmembrane helices in the secretin receptor family.
Tams, J. W., Knudsen, S. M., & Fahrenkrug, J. (1998) · PubMed · Cited by 24
Dong, M., Cox, R. F., & Miller, L. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011924 · Cited by 23
Self-citationXu, H., Wang, X., Partilla, J. S., Bishop-Mathis, K., Benaderet, T. S., Dersch, C. M., Simpson, D. S., Prisinzano, T. E., & Rothman, R. B. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.05.003 · Cited by 23
Chan, K. Y. Y., Pang, R. T. K., & Chow, B. (2001) · Endocrinology · doi:10.1210/endo.142.9.8389 · Cited by 21
Seifert, R., Gether, U., Wenzel‐Seifert, K., et al. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12645-4 · Cited by 21
Wu, S. V., Yang, M., Avedian, D., Birnbaumer, M., & Walsh, J. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23175-8 · Cited by 20
Weber, T. J., & Markillie, L. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1075 · Cited by 19
Frauenfelder, H. (1989) · Nature · doi:10.1038/338623a0 · Cited by 17
Quantitative stoichiometry of G-proteins activated by μ-opioid receptors in postmortem human brain
González‐Maeso, J., Rodríguez‐Puertas, R., & Meana, J. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02242-2 · Cited by 17
Alberts, G. L., Pregenzer, J. F., & Im, W. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703580 · Cited by 12
Localization of the Sites Mediating Desensitization of the β2-Adrenergic Receptor by the GRK Pathway
Seibold, A. M., Williams, B., Huang, Z.-F., Friedman, J., Moore, R. H., Knoll, B. J., & Clark, R. B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12491-1 · Cited by 12
G-Proteins and GPCRs: From the Beginning
Bourne, H. R. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2006_001 · Cited by 11
Allosteric Modulation of Family 3 GPCRs
Noeske, T., Gutcaits, A., Parsons, C. G., & Weil, T. (2005) · QSAR & Combinatorial Science · doi:10.1002/qsar.200510139 · Cited by 11
Cloning and pharmacological characterization of CCR7, CCL21 and CCL19 from Macaca fascicularis
Moxley, R., Day, E., Brown, K., Mahnke, M., Zurini, M. G. M., Schmitz, R., Jones, C. E., & Járai, G. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.013 · Cited by 3
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Allostery in Disease and in Drug Discovery
Nussinov, R., & Tsai, C.-J. (2013) · Cell · doi:10.1016/j.cell.2013.03.034 · Cited by 761
Metadata
- Authors
- Kenakin, T., & Miller, L. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 62
- Issue
- 2
- Pages
- 265-304
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2132746917
- Cited by
- 573
- References
- 486
- FWCI
- 27.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.